Fibrin Sealants Market to Witness Growth Acceleration by 2028

 

The global fibrin sealants market is expected to grow at a CAGR of 6.2% during the forecast period (2022-2028). The increased necessity for effective hemostasis and tissue sealing during surgery is driving the demand for fibrin sealants. Surgical tissue adhesives, which include both natural and synthetic substances, have been extended to improve hemostasis and tissue sealing during surgery. Fibrin sealants are the most effective tissue adhesives on the market. They are biodegradable and biocompatible. Human thrombin, refined, virus-inactivated human fibrinogen, and occasionally additional ingredients such as virus-inactivated human factor XIII and bovine aprotinin make up the fibrin sealants. 

Some of the key players profiled in the study are Baxter International Inc., Pfizer Inc., and Takeda Pharmaceutical Co. Ltd., among others.

Fibrin Sealants Market Segmentation:

By Type

• Liquid
• Patches

By Indication

• General Surgery
• Cardiovascular Surgery
• Wound Management
• Orthopedic Surgery 
• Others  

By End-User

• Hospitals
• Ambulatory Surgical Centers
• Others

Geographic Coverage

• North America Market Size and/or Volume
• Latin America Market Size and/or Volume
• Europe Market Size and/or Volume
• Asia-Pacific Market Size and/or Volume
• Rest of the world Market Size and/or Volume

Key questions answered in this report:

• What is the size of the Fibrin Sealants market and what is its expected growth rate?
• What are the primary driving factors that push the Fibrin Sealants Market forward?
• What are the Fibrin Sealants Industry’s top companies?
• What are the different categories that the Fibrin Sealants Market caters to?
• What will be the fastest-growing segment or region?
• In the value chain, what role do essential players play?
• What is the procedure for getting a free copy of the Fibrin Sealants Market sample report and company profiles?